Hemophilia Gene Therapy: Approaching the First Licensed Product
The clinical potential of hemophilia gene therapy has now been pursued for the past 30 years, and there is a realistic expectation that this goal will be achieved within the next couple of years with the licensing of a gene therapy product. While recent late phase clinical trials of hemophilia gene...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2021-03-01
|
| Series: | HemaSphere |
| Acceso en liña: | http://journals.lww.com/10.1097/HS9.0000000000000540 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|